drugset / Trial / NCT00391716
Gabapentin Treatment of Alcohol Dependence
Phase 2
Completed
150 enrolled
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Gabapentin treatment for alcohol dependence
Timeline
- Start
- 2004-02
- Primary completion
- 2009-07
- Completion
- 2010-02
Outcome
Met primary endpoint
paper Gabapentin significantly improved the rates of abstinence and no heavy drinking. PMID 24190578 ↗
paper 30.1%) in the 1800-mg group (P = .04 for linear dose effect; number needed to treat [NNT] = 8 for 1800 mg). PMID 24190578 ↗
paper 58.8%) in the 1800-mg group (P = .02 for linear dose effect; NNT = 5 for 1800 mg). PMID 24190578 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Unknown | 900 mg | Oral |
| Subject | Gabapentin | Unknown | 1800 mg | Oral |